Although there were only three simple dishes and one soup, Zhang Chen and Li Bozhan ate for a full hour.

The two talked about chemical drugs, protein drugs, and then cell and gene therapy, and finally expressed their views on small nucleic acid drugs, and now they are back to agriculture.

"Xiao Zhang, how sure are you that you can make a molecular farm?"

Li Bozhan remembered that Zhang Chen had said before that he would start the molecular farm in the future.

He was very interested in this area and did some research, but in the end he did not continue.

Molecular farms are much more complex than soybean yields, and he believes that with the current level of biotechnology, it is completely impossible to achieve the desired results.

"I'm planning to get involved in this field, but I'm not sure how sure I am."

Zhang Chen knows what now, he said before that he wanted to do this molecular farm, that is, he saw that there were related products in the system that could be exchanged.

But for him to mass-produce them, the specific difficulty is not known.

The molecular farm is just a general term, and there are many types of subdivisions in it, and the scientific and technological content can be very different.

The simplest, of course, is to use gene editing to enhance the efficacy of some existing Chinese herbal medicines.

Further, some compounds that can treat or prevent corresponding diseases are designed, and ways are found to make them naturally synthesized in fruits or food crops, so as to achieve the purpose of preventing or even treating diseases.

Don't look at such a method as simple as it sounds, but it is particularly difficult to do.

Nowadays, the level of science and technology is limited, and some complex compounds, even if they are synthesized artificially in vitro, are very difficult, let alone through plants, so that they can be synthesized naturally.

This must be studied very thoroughly, and its various regulatory mechanisms and signaling pathways must be clearly understood.

On this basis, it is also necessary to consider whether the compound that needs to be synthesized can be synthesized on this plant.

If it can't be synthesized, it needs to be studied in another plant and continue to match.

The characteristics of plants are strange and diverse, and the task of scientific research is extremely heavy.

However, the good news is that bioinformatics is now available, which is a completely new scientific research method.

And Zhang Chen was also prepared for a long time, and when he needed to, he could quickly pull up the team.

In addition, there are therapeutic proteins, therapeutic genes, etc., which can be produced with the help of plants.

The benefits of molecular farms speak for themselves.

Just imagine, if you eat a banana, you can continue to fight for half an hour, isn't this effect fragrant?

Eating two grapes can alleviate depression, isn't this effect six?

But to achieve it, it is quite difficult, to be happy, you have to give something.

Even if it is a hanging comparison like Zhang Chen, you have to work hard.

So he can't guarantee what he can do, but for the sake of everyone's happiness and the points that should belong to him, he will definitely do his best.

Thinking of this, Zhang Chen said firmly: "Although I don't dare to guarantee success, I will try, it is estimated that after Lanyue 001 is listed, I will set up a project and carry out this research project, Mr. Li, are you interested in participating?" ”

"I'm very interested, I must tell me when the time comes, I will bring people into the group!"

Li Bozhan should not be too interested.

He had long wanted to get involved in the field of molecular farms, but he was weak at the beginning and completely regretted that he could not move this mountain, so he could only retreat to the next best thing and start to increase soybean production.

Now that he has Zhang Chen's big help, there is no reason why he shouldn't give it a try.

And the most important thing is that the soybean yield increase has been done by Zhang Chen, and he has no choice but to do it.

"Haha, Mr. Li, you can bring people, I'm very welcome, but even if you bring money, I still have a lot of spare money, and I can still afford to spend this little expense."

Zhang Chen was amused by Li Bozhan's statement, and even brought money into the group.

"Okay, where are you going to start first?" Li Bozhan said curiously.

"Forget about the compounds, which of the current chemical drugs has no side effects? I'm going to start with the egg whites, which is a bit more difficult, but it's safe and the effect lasts a long time. ”

The chemical drugs on the market now basically have to be taken every day, and there are many side effects.

Protein drugs are injected only once every few weeks or even months, while gene therapy is a one-time solution.

Gene therapy is simple to make in vitro medicine, but it is difficult to make it naturally synthesized in plants, and there are too many problems involved.

And the protein should be naturally synthesized in plants, which is a little bit of a clue.

"Okay, I think so too, then I'll wait for good news."

Li Bozhan wiped his mouth, got up and said.

"Okay, I'll tell you as soon as the time comes," Zhang Chen also stood up, "I'll bring a lawyer over another day and sign an authorization agreement with you." ”

After the two finished eating, agreed on things, and went home separately.

The next day, September 2nd, is a big day.

Chenyue Biotechnology Co., Ltd., a gene therapy drug with the trade name Lanyue 001, will hold phase II clinical trials in many hospitals across the country.

Phase 2 clinical trials are relatively critical.

Many companies can complete phase 1 clinical trials, but they can't survive phase 2 clinical trials.

It's not that the safety of drugs is not good, in fact, most of the drugs that can be approved for clinical trials by relevant departments, and even complete phase I clinical trials, will not have potential safety hazards.

It's just that the vast majority of companies have limited funds and do not have certain economic strength, so the phase II clinical trial really can't be played.

From early research and development to phase I clinical trials, the cost is not very large.

However, in the first and second phases of clinical trials, due to the tenfold increase in the number of subjects, the cost to be borne immediately soared.

Therefore, many companies only do the first phase of clinical trials, and they choose to sell their intellectual property rights at this time and resell the results directly.

As long as the data of the phase I clinical trial is good enough, it will definitely be able to sell at a good price.

Then rely on this start-up capital to create brilliance and become bigger and stronger.

As a result, there is a very common phenomenon that many pharmaceutical companies have several drug development pipelines at the same time.

"The Legend of the Fairy Tree"

In case any project can get ahead, go to clinical trials, or even survive phase I clinical trials.

In this way, the funds can be quickly recouped and other projects can be revitalized.

And many large pharmaceutical companies are also happy to take over such innovative drugs.

A few hundred million is just a small meaning for them, what they lack is time.

How can these giants have the time to start scientific research from scratch, and if they have that time, it is better to engage in more production and make some cash.

Spending money to buy phased results is a means that many large factories are playing now.

Of course, there are also very powerful giants who directly choose to acquire small companies with scientific research results, which is another matter.

But Zhang Chen didn't have these messy ideas, he was rushing to go public from the beginning.

It's not bad money, it's not bad technology, why don't you go public?

Early in the morning, Zhang Chen took Zhang Yue and Tian Wenbin to Shaocheng People's Hospital.

The phase II clinical trial of Lanyue 001, which many people have been concerned about, is about to start!